HR and breast carcinoma: For the lung metastasis patients, it demonstrates that HR+/HER2− breast cancers rarely give rise to lung metastasis compared with TN and the HR−/HER2+ subtypes in this study and HER2 positive subtypes is prone to lung metastasis compared with HER2 negative subtypes.